Real-time enrollment status for this low-risk, early stage breast cancer clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 8:56 AM UTC
| NCT Number | NCT07629206 |
| Recruiting Status | Recruiting |
| Condition | Low-Risk, Early Stage Breast Cancer |
| Phase | NA |
| Target Enrollment | 400 participants |
| Active Locations | 2 sites in the US |
| Sponsor | IceCure Medical Ltd. |
| Last Updated on CT.gov | September 9, 2026 (Sep 9, 2026) |
As of October 17, 2026: Clinical trial NCT07629206 is currently recruiting participants. This na study for low-risk, early stage breast cancer is actively seeking new participants at 2 locations across the United States. The study is sponsored by IceCure Medical Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07629206 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07629206 was last updated Sep 9, 2026 (September 9, 2026). HelloStudys verifies this status automatically.